News

Paynela, a leading healthcare financing company revolutionizing claim processing through artificial intelligence that leverages AI advancements to process thousands of medical claims in under a minute ...
Quite a few insiders have dramatically grown their holdings in OptimizeRx Corporation ( NASDAQ:OPRX ) over the past ...
Zacks Investment Research on MSN8dOpinion
Best Growth Stocks to Buy for July 22nd
Here are three stocks with buy ranks and strong growth characteristics for investors to consider today July 22nd: OptimizeRx ...
Blackbaud (BLKB) came out with quarterly earnings of $1.21 per share, beating the Zacks Consensus Estimate of $1.05 per share. This compares to earnings of $1.08 per share a year ago. These figures ...
Last time around, it was the Federal Reserve's aggressive interest-rate hikes that finally put an end to the stock market's party in early 2022. This time, higher borrowing costs haven't done much to ...
OptimizeRx is poised for profitability by 2025 with AI-driven healthcare marketing, innovative platforms, and strong growth ...
Detailed price information for Healthstream Inc (HSTM-Q) from The Globe and Mail including charting and trades.
Detailed price information for Teladoc Health Inc (TDOC-N) from The Globe and Mail including charting and trades.
OptimizeRx OPRX is making a bold shift toward AI-driven, workflow-integrated solutions, signaling a strategic evolution that could redefine its role in digital pharma communications. On its first ...
OptimizeRx is navigating macro uncertainty with agility, benefiting from a growing base of committed revenues, cost efficiencies and a pivot to subscriptions. Continued execution in monetizing data ...